Chronix Biomedical GmbH
Industry / private company
Location:
Göttingen,
Germany (DE)
ISNI: -
Donor-Derived Cell-Free DNA as a Companion Biomarker for AMR Treatment With Daratumumab: Case Series (2024)
Osmanodja B, Akifova A, Budde K, Oellerich M, Beck J, Bornemann-Kolatzki K, Schütz E, et al.
Journal article
Comparative RNA-Seq of nine canine cell lines derived from prostate adenocarcinoma (PAC), PAC metastasis and transitional cell carcinoma (TCC) (2022)
Packeiser E, Taher L, Ernst M, Beck J, Hewicker-Trautwein M, Brenig B, Schuetz E, et al.
Conference contribution
RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures (2022)
Packeiser EM, Taher L, Kong W, Ernst M, Beck J, Hewicker-Trautwein M, Brenig B, et al.
Journal article
Suitability of ultrasound-guided fine-needle aspiration biopsy for transcriptome sequencing of the canine prostate (2019)
Thiemeyer H, Taher L, Schille JT, Harder L, Hungerbuehler SO, Mischke R, Hewicker-Trautwein M, et al.
Journal article
Combined inhibition of BTK and PI3K acts synergistically in a canine B-cell lymphoma in vitro model (2019)
Kong W, Sender S, Sekora A, Ma Y, Ruetgen B, Nolte I, Taher L, et al.
Conference contribution